Loading
Latest filing published 04 Sept 2026 for Addex Therapeutics Ltd..
No signal scores available.
Mikhail Kalinichev discloses dealings in Addex Therapeutics Ltd. to SEC (Form 4). Altogether 2 filings, all relating to 2 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 4 September 2026, reports a transaction in Addex Therapeutics Ltd. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations